Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
| Authors | John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, Christoph Hoeller, Jean-Jacques Grob, Peter Mohr, Carmen Loquai, Caroline Dutriaux, Vanna Chiarion-Sileni, Jacek Mackiewicz, Piotr Rutkowski, Petr Arenberger, Gaelle Quereux, Tarek M Meniawy, Paolo A Ascierto, Alexander M Menzies, Piyush Durani, Maurice Lobo, Federico Campigotto, Brian Gastman, Georgina V Long |
| Journal | Nature medicine
(Nat Med)
Vol. 30
Issue 2
Pg. 607
(Feb 2024)
ISSN: 1546-170X [Electronic] United States |
| PMID | 37923838
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
